GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asia Green Biotechnology Corp (XCNQ:ASIA) » Definitions » Equity-to-Asset

Asia Green Biotechnology (XCNQ:ASIA) Equity-to-Asset : -5.72 (As of Sep. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Asia Green Biotechnology Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Asia Green Biotechnology's Total Stockholders Equity for the quarter that ended in Sep. 2023 was C$-0.34 Mil. Asia Green Biotechnology's Total Assets for the quarter that ended in Sep. 2023 was C$0.06 Mil.

The historical rank and industry rank for Asia Green Biotechnology's Equity-to-Asset or its related term are showing as below:

XCNQ:ASIA' s Equity-to-Asset Range Over the Past 10 Years
Min: -5.72   Med: 0.84   Max: 0.97
Current: -5.72

During the past 5 years, the highest Equity to Asset Ratio of Asia Green Biotechnology was 0.97. The lowest was -5.72. And the median was 0.84.

XCNQ:ASIA's Equity-to-Asset is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.59 vs XCNQ:ASIA: -5.72

Asia Green Biotechnology Equity-to-Asset Historical Data

The historical data trend for Asia Green Biotechnology's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asia Green Biotechnology Equity-to-Asset Chart

Asia Green Biotechnology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Equity-to-Asset
0.77 0.92 0.94 -0.66 -4.04

Asia Green Biotechnology Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.59 -4.04 -4.87 -5.32 -5.72

Competitive Comparison of Asia Green Biotechnology's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Asia Green Biotechnology's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asia Green Biotechnology's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Asia Green Biotechnology's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Asia Green Biotechnology's Equity-to-Asset falls into.



Asia Green Biotechnology Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Asia Green Biotechnology's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )=Total Stockholders Equity/Total Assets
=-0.275/0.068
=

Asia Green Biotechnology's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )=Total Stockholders Equity/Total Assets
=-0.343/0.06
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asia Green Biotechnology  (XCNQ:ASIA) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Asia Green Biotechnology Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Asia Green Biotechnology's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Asia Green Biotechnology (XCNQ:ASIA) Business Description

Traded in Other Exchanges
N/A
Address
707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
Asia Green Biotechnology Corp is an early stage international agri-technology company focused on the development, evaluation, testing, application and, ultimately, supply to the market of proprietary organic hybridization technology and certain products derived from that technology. The core approach of the business is centred on the planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities. The company is developing varieties of hemp with superior growth and production characteristics in the various environments found in the licensed territories.

Asia Green Biotechnology (XCNQ:ASIA) Headlines

No Headlines